SiteBridge Research, together with iParticipate, is kicking off its annual Bridging the Gap in Clinical Trials Arts contest. This effort officially launches SiteBridge's community engagement program and aims to connect the arts, sciences, and community in support of clinical trial participation.
The contest began on June 14 with voting commencing on August 7. Winners will be notified on November 20. It will feature talent across four categories: visual art, music, photography, and dance.
SiteBridge's creative collaboration with iParticipate, incorporated in the "Bridging the Gap" initiative compels industry to examine how it addresses disparities and how it portrays clinical trials—especially to communities of color and other underrepresented populations—and will explore the potential for impact.
Read more about the initiative and contest here.
Bridging the Gap Community Engagement Program. (2023, June 14). SiteBridge Research.
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
February 6th 2025In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative breast cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.